click below
click below
Normal Size Small Size show me how
Chloramphenicol
| Question | Answer |
|---|---|
| Mode of action | Bacteriostatic . Potent inhibitor of microbial protein synthesis . Binds irreversibly to 50s subunit and inhibits the peptidyl transferase step of protein synthesis.. |
| Antimicrobial activity | Wide spectrum . Active against both aerobic and anaerobic gram + and - organisms. Bactericidal to certain drugs H.influenzae, N. Meningitis , streptococcus pneumoniae |
| Pharmacokinetics | Half life 5 hours. Available as oral, Parentaral and topical preparations. Widely distributed in body fluids and tissues. |
| Excretion | Kidneys |
| Adverse effects | Nausea , vomiting , diarrhea . Oral and vaginal candidiasis . Haematological effects. |
| Toxicity to neonates | Grey baby syndrome |
| Drug interactions | Irreversibly inhibits hepatic microsomal cytochrome p450 system . Enzyme induction due to phenobarbital and rifampicin ahortens the half life of chloramphenicol. |
| Therapeutic uses | Bacterial meningitis, Typhoid fever, Rickettsial disease, Topical application |
| Fusidic acid | Acts by inhibiting protein synthesis |
| Antimicrobial activity | Narrow spectrum steroid antibiotic. Active mainly against gram +. Used against beta lactamase producing staphylococcus. |
| Pharmacokinetics | Half life 5 hours. Widely distributed in body. Excretd in urine. |
| Adverse effects | Mild gi disturbances. Reversible jaundice. Rarely rashes and blood disorders. |
| Uses | In osteomyelitis, Staphylococcal endocarditis . |
| Topical preparations used for | Staphylococcal skin infections, Eradication of staphylococcal nasal carriers, Staphylococcal conjunctivitis |